ARCHIVES

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

This article is from The Cancer Letter archive.

Vol. 32 No. 04 | February 3, 2006

Download PDF Visit The Full Archive

Related Articles

New Data Support Claims That Costs Are Higher For Protocol Patients

August 31, 1984

NCAB Votes No To Funding Diet FIT, Citing NCI Resources

December 8, 1989

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

Creating the Modern Cancer Center

November 2, 2021